WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 510.76B
Enterprise Value 39.94B
Trailing P/E 48.31
Forward P/E 142.52
PEG Ratio (5 yr expected) 15.25
Price/Sales (ttm)6.09
Price/Book (mrq)7.44
Enterprise Value/Revenue 35.63
Enterprise Value/EBITDA 626.24

Trading Information

Stock Price History

Beta (3Y Monthly) 1.37
52-Week Change 325.69%
S&P500 52-Week Change 32.36%
52 Week High 3147.19
52 Week Low 391.75
50-Day Moving Average 3133.09
200-Day Moving Average 3118.10

Share Statistics

Avg Vol (3 month) 3284.94k
Avg Vol (10 day) 3197.25k
Shares Outstanding 573.48M
Float 73.07M
% Held by Insiders 10.96%
% Held by Institutions 195.22%
Shares Short (Jul 15, 2019) 4481.92k
Short Ratio (Jul 15, 2019) 41.81
Short % of Float (Jul 15, 2019) 40.75%
Short % of Shares Outstanding (Jul 15, 2019) 40.66%
Shares Short (prior month Jun 14, 2019) 4595.49k

Dividends & Splits

Forward Annual Dividend Rate 40.64
Forward Annual Dividend Yield 40.47%
Trailing Annual Dividend Rate 30.59
Trailing Annual Dividend Yield 30.40%
5 Year Average Dividend Yield 40.63
Payout Ratio 419.54%
Dividend Date 3Nov 6, 2019
Ex-Dividend Date 4Oct 22, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Sep 27, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 12.94%
Operating Margin (ttm)15.54%

Management Effectiveness

Return on Assets (ttm)8.59%
Return on Equity (ttm)16.77%

Income Statement

Revenue (ttm)1.77B
Revenue Per Share (ttm)23.90
Quarterly Revenue Growth (yoy)5.00%
Gross Profit (ttm)545.4M
Net Income Avi to Common (ttm)228.7M
Diluted EPS (ttm)3.02
Quarterly Earnings Growth (yoy)17.80%

Balance Sheet

Total Cash (mrq)326.7M
Total Cash Per Share (mrq)4.43
Total Debt (mrq)272.6M
Total Debt/Equity (mrq)18.86
Current Ratio (mrq)3.02
Book Value Per Share (mrq)19.59

Cash Flow Statement

Operating Cash Flow (ttm)314.3M
Levered Free Cash Flow (ttm)115.25M